Capital Markets Trading Uk LLP Bristol Myers Squibb CO Transaction History

Capital Markets Trading Uk LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $1.65 Million - $1.92 Million	-30,735 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $1.82 Million - $2.13 Million	30,735 New	30,735 $1.86 Million
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $286,024 - $311,480	-4,620 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $274,150 - $308,338	4,620 New	4,620 $292,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $1.72 Million - $1.9 Million	-29,870 Closed	0 $0

Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.64 Million - $1.91 Million	29,870 New	29,870 $1.76 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $770,054 - $1.12 Million	-16,596 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $816,689 - $1.07 Million	16,596 New	16,596 $1.07 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $523,804 - $621,045	-12,247 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $394,306 - $436,017	8,837 Added 259.15%	12,247 $555,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $631,003 - $752,393	-13,985 Reduced 80.4%	3,410 $163,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $848,180 - $1.1 Million	17,395 New	17,395 $904,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1.1 Million - $1.24 Million	-19,961 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $30,722 - $38,291	-608 Reduced 2.96%	19,961 $1.11 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $1.23 Million - $1.42 Million	20,569 New	20,569 $1.3 Million

2,553

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Capital Markets Trading Uk LLP, based on Form 13F filings with the SEC.

Stay updated on Capital Markets Trading Uk LLP with notifications on news.